4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-21-112499
Director sold 4,000 shares at $9.40 ($37,591)
- Director acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2021-08-31 | Option exercise | +4,000 | $4.13 | $16,500 | 129,046 | D |
| Kraus Al Director | 2021-08-31 | Sale | −4,000 | $9.40 | $37,591 | 125,046 | D |
| Derivatives | |||||||
| Kraus Al Director | 2021-08-31 | Option exercise · Stock Option (right to buy) | −4,000 | 0 | D | ||
| Open-market sales · 4,000 sh · avg $9.40 · $37,591 | |||||||
Loading xslF345X03/tm2126875-1_4seq1.xml…